A. Antonov

发表

Polypharmacology of small molecules targeting the ubiquitin–proteasome and ubiquitin-like systems

I. Amelio, V. Landré, R. Knight, 2015, Oncotarget.

Polypharmacology of Approved Anticancer Drugs.

I. Amelio, R. Knight, A. Lisitsa, 2017, Current drug targets.

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

S. Lipton, A. Ciechanover, T. Luedde, 2018, Cell Death & Differentiation.

The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration

A. Antonov, A. Hall, S. Moxon, 2016, Cell Death and Disease.

DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information

R A Knight, G Melino, A E Willis, 2014, Cell Death and Disease.

Exploration of individuality in drug metabolism by high-throughput metabolomics: The fast line for personalized medicine.

R. Knight, A. Lisitsa, G. Melino, 2016, Drug discovery today.

Large scale integration of drug-target information reveals poly-pharmacological drug action mechanisms in tumor cell line growth inhibition assays

R. Knight, G. Melino, A. Antonov, 2014, Oncotarget.

p63 controls cell migration and invasion by transcriptional regulation of MTSS1

E. Markert, G. Melino, A. Antonov, 2016, Oncogene.

The Cul4A–DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity

D. Green, G. Melino, A. Antonov, 2013, Oncogene.

Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease

X. M. Sun, A. Antonov, S. Galavotti, 2016, Cell Death and Differentiation.

Characterization of novel markers of senescence and their prognostic potential in cancer

A. Antonov, C. Pritchard, S. Macip, 2014, Cell Death and Disease.

Human EHMT 2 activates p 53 through methylation-independent mechanism

Sal, G. Melino, A. Antonov, 2016 .

Human EHMT2/G9a activates p53 through methylation-independent mechanism

G. Melino, A. Antonov, N. Barlev, 2017, Oncogene.

SynTarget: an online tool to test the synergetic effect of genes on survival outcome in cancer

I. Amelio, R. Knight, A. Lisitsa, 2016, Cell Death and Differentiation.

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

S. Lipton, A. Ciechanover, T. Luedde, 2018, Cell Death & Differentiation.

miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress

M. Ivan, G. Melino, A. Antonov, 2013, Cell Death and Disease.

Caspase-1 is a novel target of p63 in tumor suppression

I. Amelio, G. Melino, A. Antonov, 2013, Cell Death and Disease.

p73 regulates serine biosynthesis in cancer

A. Levine, E. Markert, I. Amelio, 2014, Oncogene.

KMT Set7/9 affects genotoxic stress response via the Mdm2 axis

G. Melino, A. Antonov, O. Fedorova, 2015, Oncotarget.

E3 ubiquitin ligase Pirh2 enhances tumorigenic properties of human non-small cell lung carcinoma cells

A. Antonov, O. Fedorova, N. Barlev, 2016, Genes & cancer.

Rapamycin regulates biochemical metabolites

G. Melino, A. Antonov, M. Agostini, 2013, Cell cycle.

Alterations in neuronal metabolism contribute to the pathogenesis of prion disease

A. Antonov, A. Tobin, J. Steinert, 2018, Cell Death & Differentiation.

DNA damage modulates interactions between microRNAs and the 26S proteasome

A. Antonov, V. Kulichkova, A. Tsimokha, 2014, Oncotarget.

KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress

G. Melino, A. Antonov, I. Talianidis, 2014, Cell Death and Differentiation.

MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets

R. Knight, G. Melino, A. Antonov, 2012, Cell Death and Differentiation.

PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome

R A Knight, G Melino, I. Rodchenkov, 2014, Oncogene.

p53MutaGene: an online tool to estimate the effect of p53 mutational status on gene regulation in cancer

I. Amelio, R. Knight, A. Lisitsa, 2016, Cell Death and Disease.

BIOINFORMATICS APPLICATIONS NOTE

H. Mewes, I. Tetko, A. Antonov, 2004 .

Alterations in neuronal metabolism contribute to the pathogenesis of prion disease

A. Antonov, A. Tobin, J. Steinert, 2018, Cell Death & Differentiation.

Abstract 4657: Evaluation of genomic profiling in the GALAXY-1 (NCT01348126), a randomized Phase 2b study of ganetespib in combination with docetaxel versus docetaxel alone as second line therapy in patients with advanced NSCLC

A. Antonov, S. Ramalingam, D. Fennell, 2014 .

Large scale integration of drug-target information reveals poly-pharmacological drug action mechanisms in tumor cell line growth inhibition assays

R. Knight, G. Melino, A. Antonov, 2014, Oncotarget.